deoxycytidine - CISMeF

Preferred Label : deoxycytidine;

MeSH definition : A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE.;

MeSH synonym : deoxyriboside, cytosine; cytosine deoxyriboside; cytosine deoxyribonucleoside; deoxyribonucleoside, cytosine;

CISMeF synonym : 2'-deoxycytidine; cdr;

MeSH CAS label : cytidine, 2'-deoxy-;

MeSH Related Number : 951-77-9 (Deoxycytidine);

Registry Number MeSH : 951-77-9;

Wikipedia link : https://en.wikipedia.org/wiki/Deoxycytidine;

Codes EINECS : 213-454-1;

Is substance : O;

UNII : 0W860991D6;

InChIKey : CKTSBUTUHBMZGZ-SHYZEUOFSA-N;

Details

Origin ID

D003841;

UMLS CUI

C0011485;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- 2'-deoxycytidine [Substance BNPC]
Currated CISMeF NLP mapping
- Doxecitine [NCIt concept]
Indexing information
- 2'-deoxyribofuranosyl-2-oxopyrimidine-4-diazoate [MeSH Supplementary Concept]
Record concept(s)
- deoxycytidine [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-((3-hydroxy)-4-(hydroxymethyl)cyclopentyl)-4-amino-5-(2-bromovinyl)-2(1H)-pyrimidinone [MeSH Supplementary Concept]
- 1-(2-amino-3-hydroxy-4-(hydroxymethyl)cyclopentyl)-2(1H)-pyrimidinone [MeSH Supplementary Concept]
- 1-methyl-2'-deoxypseudoisocytidine [MeSH Supplementary Concept]
- 2',3'-O-diacetyl-5'-deoxy-5-vinylcytidine [MeSH Supplementary Concept]
- 2',3'-didehydro-2',3'-dideoxy-5-chlorocytidine [MeSH Supplementary Concept]
- 2',3'-dideoxy-3'-fluorocytidine [MeSH Supplementary Concept]
- 2',5-dichloro-2'-deoxycytidine [MeSH Supplementary Concept]
- 2'-deoxy-(fluoromethylene)cytidine [MeSH Supplementary Concept]
- 2'-deoxy-2'-(hydroxylamino)cytidine [MeSH Supplementary Concept]
- 2'-deoxy-2'-C-difluoromethylene-4'-thiocytidine [MeSH Supplementary Concept]
- 2'-deoxy-2'-ethylcytidine [MeSH Supplementary Concept]
- 2'-deoxy-2'-fluoro-2'-C-methylcytidine [MeSH Supplementary Concept]
- 2'-deoxy-2'-fluoro-4'-azidocytidine [MeSH Supplementary Concept]
- 2'-deoxy-2'-isocyano-1-arabinofuranosylcytosine [MeSH Supplementary Concept]
- 2'-deoxy-2'-methylenecytidine [MeSH Supplementary Concept]
- 2'-deoxy-2'-methylidene-5-fluorocytidine [MeSH Supplementary Concept]
- 2'-deoxy-3'-oxa-thiocytidine [MeSH Supplementary Concept]
- 2'-deoxy-4'-thiocytidine [MeSH Supplementary Concept]
- 2'-deoxy-5,6-dihydrocytidine [MeSH Supplementary Concept]
- 2'-deoxy-5-(methylselenyl)cytidine [MeSH Supplementary Concept]
- 2'-deoxy-5-fluoro-3'-thiacytidine [MeSH Supplementary Concept]
- 2'-deoxy-5-propynylcytidine [MeSH Supplementary Concept]
- 2'-deoxy-N(4)-methoxycytidine [MeSH Supplementary Concept]
- 2'-deoxy-N(4)-nitrosocytidine [MeSH Supplementary Concept]
- 2'-deoxy-N-(1-naphthylcarbamoyl)cytidine [MeSH Supplementary Concept]
- 2'-deoxy-N-(phenylcarbamoyl)cytidine [MeSH Supplementary Concept]
- 2'-deoxycytidine glycol [MeSH Supplementary Concept]
- 2'-deoxycytidine-N-oxide [MeSH Supplementary Concept]
- 2'-fluoro-2'-deoxycytidine [MeSH Supplementary Concept]
- 2'-fluoro-2'-methyl-3',5'-diisobutyryldeoxycytidine [MeSH Supplementary Concept]
- 2'-methyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 3'-deoxy-3'-(hydroxylamino)cytidine [MeSH Supplementary Concept]
- 3'-deoxycytidine [MeSH Supplementary Concept]
- 3,N(4)-ethenodeoxycytidine [MeSH Supplementary Concept]
- 3-(2'-deoxyribofuranosyl)furano(2,3-d)pyrimidine-6(5H)-one [MeSH Supplementary Concept]
- 3-amino-2'-deoxycytidine [MeSH Supplementary Concept]
- 3-deaza-2'-deoxycytidine [MeSH Supplementary Concept]
- 3-ethanesulfonic acid 2'-deoxycytidine [MeSH Supplementary Concept]
- 3-hydroxy-1,N(4)-benzetheno-2'-deoxycytidine [MeSH Supplementary Concept]
- 336 5'-FU [MeSH Supplementary Concept]
- 354 5'-DFCR [MeSH Supplementary Concept]
- 4'-C-ethynyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 4'-azido-2'-deoxy-2'-methylcytidine [MeSH Supplementary Concept]
- 4'-azido-2'-deoxyfluoroarabinocytidine [MeSH Supplementary Concept]
- 4'-azido-2'-dideoxy-2',2'-difluorocytidine [MeSH Supplementary Concept]
- 4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine [MeSH Supplementary Concept]
- 4'-thio-2'-deoxy-2'-methylidenecytidine [MeSH Supplementary Concept]
- 4-(N)-lauroylgemcitabine [MeSH Supplementary Concept]
- 4-(N)-stearoylgemcitabine [MeSH Supplementary Concept]
- 4-(N)-tris-nor-qualenoyl-gemcitabine [MeSH Supplementary Concept]
- 4-N-(N,N-dimethylaminomethylidenyl)-5-(3-(1-pyrenecarboxamido)propynyl)-5'-O-(4,4-dimethoxytrityl)-2'-deoxycytidine [MeSH Supplementary Concept]
- 4-N-acetyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 4-N-carbamoyldeoxycytidine [MeSH Supplementary Concept]
- 4-amino-1-(2-azido-3-hydroxy-4-(hydroxymethyl)cyclopentyl)-2(1H)-pyrimidinone [MeSH Supplementary Concept]
- 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-ethynylpyrimidin-2(1H)-one [MeSH Supplementary Concept]
- 4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one [MeSH Supplementary Concept]
- 4N-acetyldeoxycytidine [MeSH Supplementary Concept]
- 5'-O-carbamate-2',3'-dideoxythiacytidine [MeSH Supplementary Concept]
- 5'-O-dimethoxytrityl-N(4)-benzoyl-5-methyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5'-S-(5-acetamido-2,3,5-trideoxy-2-nonulopyranosylonic acid)-5'-thiocytidine [MeSH Supplementary Concept]
- 5'-deoxy-5-fluorocytidine [MeSH Supplementary Concept]
- 5,6-dihydro-5-aza-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-(1-phenyl-1,2,3-triazol-4-yl)-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-(2-pyridylethynyl)-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-carbamoylvinyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-carboxydeoxycytidine [MeSH Supplementary Concept]
- 5-carboxyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-chloro-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-ethyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-ethynyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-fluoro-2',3'-dideoxycytidine [MeSH Supplementary Concept]
- 5-fluoro-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-fluoro-N(4)-hydroxy-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-formyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-hydroxy-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-hydroxymethyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-methoxymethyl-2-deoxycytidine [MeSH Supplementary Concept]
- 5-methoxymethyl-N(4)-methyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-methyl-2'-deoxycytidylyl-(3'-5')-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-methyl-2'-deoxycytidylyl-(3'-5')-thymidine [MeSH Supplementary Concept]
- 5-methyldeoxycytidine [MeSH Supplementary Concept]
- 5-trifluoromethyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-vinyl-2'-deoxycytidine [MeSH Supplementary Concept]
- 6-keto-2'-deoxy-5-methylcytidine [MeSH Supplementary Concept]
- 8-(hydroxymethyl)-3,N(4)-etheno-2'-deoxycytidine [MeSH Supplementary Concept]
- ABVG protocol [MeSH Supplementary Concept]
- BCH-335 [MeSH Supplementary Concept]
- CGV protocol [MeSH Supplementary Concept]
- CP 4126 [MeSH Supplementary Concept]
- DFP-10917 [MeSH Supplementary Concept]
- ECarboX protocol [MeSH Supplementary Concept]
- FFG protocol [MeSH Supplementary Concept]
- FOLFUGEM protocol [MeSH Supplementary Concept]
- FddCMP-bisSate [MeSH Supplementary Concept]
- GAP protocol [MeSH Supplementary Concept]
- GDP protocol [MeSH Supplementary Concept]
- GET protocol [MeSH Supplementary Concept]
- GIP protocol [MeSH Supplementary Concept]
- GOLF protocol [MeSH Supplementary Concept]
- GV protocol [MeSH Supplementary Concept]
- KPC34 compound [MeSH Supplementary Concept]
- N(3)-methyl-2'-deoxycytidine [MeSH Supplementary Concept]
- N(4)-(1(b),2(a),3(a)-trihydroxy-4(b)-1,2,3,4-tetrahydronaphthyl)-2'-deoxycytidine [MeSH Supplementary Concept]
- N(4)-(6-aminopyridin-2-yl)-2'-deoxycytidine [MeSH Supplementary Concept]
- N(4)-(N(2)-acetamidoureido)-5'-O-4-4'-dimethoxytrityl-5-methyl-2'-deoxycytidine [MeSH Supplementary Concept]
- N(4)-(N-(6-trifluoroacetylamidocaproyl)-2-aminoethyl)-5'-O-dimethoxytrityl-5-methyl-2'-deoxycytidine-3'-N,N-diisopropylmethylphosphoramidite [MeSH Supplementary Concept]
- N(4)-ureido-5'-O-4-4'-dimethoxytrityl-5-methyl-2'-deoxycytidine [MeSH Supplementary Concept]
- N,N-dimethyl-5-methoxymethyl-2'-deoxycytidine [MeSH Supplementary Concept]
- N-(4,9,13-triazatridecan-1-yl)-2'-deoxycytidine [MeSH Supplementary Concept]
- N-4-anisoyl-2'-deoxycytidine [MeSH Supplementary Concept]
- N-4-ethyl-2'-deoxycytidine [MeSH Supplementary Concept]
- N-benzoyl-2'-deoxypseudoisocytidine [MeSH Supplementary Concept]
- N-octadecanoyl gemcitabine [MeSH Supplementary Concept]
- N4-(N'-phenylcarbamoyl)-2'-deoxycytidine [MeSH Supplementary Concept]
- N4-carboxymethyl-2'-deoxycytidine [MeSH Supplementary Concept]
- NEO 6002 [MeSH Supplementary Concept]
- Ro 09-1390 [MeSH Supplementary Concept]
- TVTG protocol [MeSH Supplementary Concept]
- XELOX [MeSH Supplementary Concept]
- ZRX1 compound [MeSH Supplementary Concept]
- apricitabine [MeSH Supplementary Concept]
- azvudine [MeSH Supplementary Concept]
- capecitabine-irinotecan combination [MeSH Supplementary Concept]
- cholesteryl-phosphonyl gemcitabine [MeSH Supplementary Concept]
- dodecyl-3-((1-(3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)carbamoyl)pyrazine-2-carboxylate [MeSH Supplementary Concept]
- gemcitabine-oxaliplatin regimen [MeSH Supplementary Concept]
- ibacitabine [MeSH Supplementary Concept]
- monoval-2'-deoxy-beta-L-cytidine [MeSH Supplementary Concept]
- poly-1-glutamic acid-gemcitabine [MeSH Supplementary Concept]
- pyrrolo-deoxycytidine [MeSH Supplementary Concept]
- tezacitabine [MeSH Supplementary Concept]
- thymidylyl-(3'-5')-5-methyl-2'-deoxycytidine [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
UMLS correspondences (same concept)
- 2'-deoxycytidine [Substance BNPC]
- Doxecitine [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients